Indiana University School of Medicine researchers have identified a new therapeutic target that could lead to more effective treatment of glaucoma.
Mar 10, 2023
0
40
A new, detailed genetic roadmap of glaucoma—the world's leading cause of irreversible blindness—will help researchers develop new drugs to combat the disease, by identifying potential target areas to stall or reverse ...
Jun 8, 2022
0
73
The U.S. Preventive Services Task Force (USPSTF) concludes that evidence for weighing the balance of benefits and harms of screening adults aged 40 years or older for primary open-angle glaucoma is currently inadequate. These ...
Oct 26, 2021
0
1
A popular class of diabetes medications called GLP-1R agonists (Trulicity and Rybelsus) may also protect against glaucoma in diabetic patients, according to a new study led by researchers in the Scheie Eye Institute at the ...
Sep 20, 2021
0
16
A team of researchers from LSU Health New Orleans Neuroscience Center of Excellence and the University of Copenhagen provides the first evidence that patients with ocular hypertension may exhibit superior antioxidant protection ...
Sep 17, 2020
0
11
A global research team led by scientists from Singapore and the United States has discovered new evidence that there is an underlying link between degeneration of the eye and brain. They found that genetic variation at a ...
Nov 6, 2019
0
818
(HealthDay)—Patients with glaucoma generally find an electronic health record (EHR)-linked reminder system for glaucoma medications useful, according to a study published online Dec. 13 in JAMA Ophthalmology.
Dec 14, 2018
0
0
A 12-year-old Duke University spinoff founded by two Duke professors has received regulatory approval for its first drug: once-a-day eye drops for glaucoma patients.
Jan 3, 2018
0
8
Less than one-third of patients with glaucoma talk to their doctor about the costs of medications needed to control their disease, reports a study in the December issue of Optometry and Vision Science, the official journal ...
Dec 2, 2017
0
2
Scientists have found a variation of the miR-182 gene in patients with primary open-angle glaucoma that results in this overexpression, said Dr. Yutao Liu, vision scientist and human geneticist in the Department of Cellular ...
Aug 15, 2016
0
0
